Janssen’s coronavirus vaccine will be tested in 190 Spanish volunteers and the study will last between 4 and 6 months Source: www.redaccionmedica.com Spain begins, this week, […]
Source: actasanitaria.com The Spanish Agency for Medicines and Health Products (AEMPS) has published a series of recommendations for action in the event of Covid-19 infection in the […]
HIR researchers have described the role of B3 integrin in cell-to-cell communication, key to the development of metastases. Source: www.immedicohospitalario.es A team of researchers from the Translational […]
Source: www.immedicohospitalario.es The three hospitals participating in the research; La Paz y la Princesa in Madrid and Valdecilla in Santander, have already recruited the participating volunteers. […]
Source: www.farmaindustria.es Within the terrible pandemic that plagues the world there has been some good news, such as the demonstration of Spain’s leadership in clinical research. […]
Many digital solutions put into practice during the pandemic, such as remote monitoring, can help consolidate Spain’s leadership in clinical drug trials.Farmaindustria participates in the Covid-19 […]
Source: www.actasanitaria.com The Council of Ministers has authorized, on Tuesday, July 7, the Carlos III Health Institute (ISCIII), the call for grants for independent clinical research […]
Source: www.actasanitaria.com “Investment in research and the recovery of offshoring production are the bases to reactivate the Spanish economy from the pharmaceutical industry”, as detailed by […]
Source: https://www.immedicohospitalario.es/ 06-22-2020 The results analyze the evolution of 13,500 patients from 174 hospitals thanks to the work of more than 1,000 Hospital Pharmacists that reveal […]
The president of Farmaindustria appears before the Commission for Social and Economic Reconstruction presenting the position of the pharmaceutical industry The pharmaceutical sector has proved essential […]
Representatives of the Spanish Medicines Agency, patient associations, hospitals and the pharmaceutical industry debate in a webinar on how to promote clinical research in Spain Measures […]
On May 20, Clinical Trial Day is celebrated worldwide About 80% of the studies that are launched in Spain are driven by the pharmaceutical industry Spain […]
Source: www.immedicohospitalario.es Since 2018, Novo Nordisk Spain has increased the number of patients in clinical trials by 50%, as detailed by Fernando Fuentes, head of Clinical […]
This chronic disease has an incidence of between 3 and 7% of the population in Spain, according to experts Treatments provide clear results in patients’ health […]
In just a few months, Spain has launched 64 clinical trials with potential anti-coronavirus drugs, ranking first in Europe and fourth in the world. The brutal […]
Farmaindustria participates in a Eupati webinar aimed at patients from all over Spain Explain how laboratories are working, in collaboration with researchers and hospitals, so that […]
Via: www.elglobal.es Clinical and industry experts carry out a decalogue with measures to strengthen the Spanish research system In recent years, Spain has positioned itself among […]
Via: www.immedicohospitalario.es Farmaindustria has collected in a document the measures that 120 experts from hospital centers and pharmaceutical companies propose to boost Spanish leadership and attract […]
Source: www.actasanitaria.com The Spanish Agency of Medicines and Health Products (AEMPS), as the competent national authority in the authorization of clinical trials, has proposed a series […]
The European employer of the innovative industry has its sights set on the roadmap of the Industrial Strategy for the sector, which will be published next […]
Source: www.expansion.com The pharmaceutical industry is positioned as a leading actor for the necessary evolution of the Spanish economy towards a productive model supported by innovation […]
Source: www.immedicohospitalario.es The clinical efficacy of this new diagnosed tool has been tested in five hospitals with clinical trials, which is a step towards personalized medicine […]
Source: www.immedicohospitalario.es The arrival of advanced therapies, such as CAR-T cells, immunotherapy or other targeted treatments and their incorporation into the assistance protocols are being able […]
Farmaindustria advocates strengthening the role of the Spanish Agency for Medicines and Health Products (Aemps) to maintain the competitiveness of our country in biomedical R&D The […]
The impulse to biomedical research in this area allows disease control for longer, increases survival and improves the quality of life of patients The Spanish Agency […]
They are essential to demonstrate the safety of medicines, but they also represent a significant cost savings in the health centers where they are carried out. […]
Source: www.actasanitaria.es Farmaindustria has reported that the Economic and Social Council (CES), a consultative body of the Government in socio-economic and labor matters, published a comprehensive […]
The Code of Conduct regulating the processing of personal data in clinical trials approved in 2022 makes it easier for companies and researchers to correctly comply […]
The director of Farmaindustria’s Access Department, Isabel Pineros, participates in the XVI International Congress on Rare Diseases: “In recent years we have seen great advances in […]
This is demonstrated by a recent study by Professor Frank R. Lichtenberg of Columbia University, which has just been published in the journal Value in Health. […]
On World Disease Day, which is celebrated on October 19, Farmaindustria remembers the importance of clinical trials, the previous step for the arrival of innovative treatments […]
The document proposes, without the need for a regulatory change, a procedure that would allow the equitable arrival of drugs that meet certain criteria that make […]
elglobal.es In a political context with elections called for the European Parliament at the beginning of June 2024 and with Spain holding the presidency of […]
Between 2020 and 2022, 446 clinical trials with children and adolescents were conducted in our country, almost half of them focused on rare diseases and 90.4% […]
In recent years, the number of applications capable of interacting with patients to prevent, manage or treat diseases has increased, and which can also generate data […]
The 7th Congress of Patients’ Organisations, organised by the POP, analyses the application of the new European Regulation on Clinical Trials. Farmaindustria’s director general, Juan Yermo, […]
Only 7.5% are carried out in health centres. In order to alleviate this situation, Farmaindustria has presented a programme to promote them in outpatient clinics. Source: […]
“We are going to create a favourable environment”. This statement by José Manuel Miñones is the first step towards a roadmap that would highlight the key […]